The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

Share Price Information for FD Technologies (FDP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,326.00
Bid: 1,328.00
Ask: 1,338.00
Change: 10.00 (0.76%)
Spread: 10.00 (0.753%)
Open: 1,336.00
High: 1,338.00
Low: 1,326.00
Prev. Close: 1,316.00
FDP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of General Meeting

3 Mar 2015 11:06

RNS Number : 3933G
First Derivatives PLC
03 March 2015
 

3 March 2015

 

First Derivatives PLC

("FD" or the "Company")

 

Result of General Meeting

Application for admission of new ordinary shares

 

FD (AIM:FDP.L, ESM:FDP.I), a leading provider of software and consulting services, announced on 12 February 2015 that the Company had placed 200,003 new ordinary shares (the "Placing Shares") conditional upon approval by shareholders at a General Meeting which was held earlier today.

 

The Company is pleased to confirm that the resolution proposed at the General Meeting was duly passed without amendment. As a result, the Placing Shares will be issued, allotted and admitted to trading on AIM and the ESM on 4 March 2015.

 

In addition, further to the announcement on 26 February 2015, FD confirms that the acquisition of Prelytix LLC was completed and that the Company has now issued and allotted 74,572 new ordinary shares (the "Consideration Shares") in respect of the initial consideration.

 

Application has been made for the Consideration Shares to be admitted to trading on AIM and the ESM and it is expected that admission will also take place on 4 March 2015. 

 

The Placing Shares and the Consideration Shares will rank pari passu with the Company's existing ordinary shares.

 

The current total issued share capital of the Company is 22,702,201 ordinary shares. Following admission of the Placing Shares and the Consideration Shares the total issued share capital of the Company will increase to 22,976,776 ordinary shares. This figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a charge to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules. The Company does not hold any shares in treasury and therefore the total number of voting rights in the Company will be 22,976,776.

 

 

Enquiries:

First Derivatives plc

Brian Conlon, Chief Executive Officer

Graham Ferguson, Finance Director

Ian Mitchell, Head of Investor Relations

+44(0)28 3025 2242

www.firstderivatives.com

Charles Stanley Securities

(Nominated Adviser and Broker)

Russell Cook

Carl Holmes

+44 (0)20 7149 6000

Goodbody

(ESM Adviser and Broker)

Linda Hickey

Finbarr Griffin

+353 1 667 0420

Walbrook PR

Financial PR

Sam Allen

+44 (0)20 7933 8780

 

 

About First Derivatives

FD is a global technology provider with nearly 20 years of experience of working with some of the world's largest finance, technology and energy institutions. It holds a 65% stake in Palo Alto-based Kx Systems, developer of the world-leading database technology, kdb+. It employs over 1,200 people worldwide and has operations in London, New York, Stockholm, Singapore, Hong Kong, Sydney, Toronto, Philadelphia, Dublin and its headquarters in Newry.

For further information please visit www.firstderivatives.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ROMPKNDKDBKDPNK
Date   Source Headline
9th Dec 20219:40 amRNSDirector/PDMR Shareholding
1st Dec 20211:55 pmRNSHolding(s) in Company
30th Nov 202110:52 amRNSTotal Voting Rights
18th Nov 20217:00 amRNSAppointment of Adviser
15th Nov 20215:12 pmRNSIssue of Equity
9th Nov 20218:48 amRNSHolding(s) in Company
2nd Nov 20217:00 amRNSResults for the six months ended 31 August 2021
11th Oct 20217:00 amRNSHolding(s) in Company
6th Oct 20214:27 pmRNSHolding(s) in Company
6th Oct 20217:00 amRNSNotice of Results
1st Sep 20219:29 amRNSTotal Voting Rights
25th Aug 20215:37 pmRNSIssue of Equity
11th Aug 20217:00 amRNSLTIP Award
30th Jul 20217:00 amRNSDirectorate Change
8th Jul 20215:23 pmRNSResult of AGM
2nd Jul 202111:47 amRNSHolding(s) in Company
30th Jun 202112:16 pmRNSTotal Voting Rights
22nd Jun 20215:44 pmRNSIssue of Equity
15th Jun 20211:20 pmRNSHolding(s) in Company
14th Jun 20215:05 pmRNSHolding(s) in Company
8th Jun 20215:19 pmRNSNotice of AGM & Change of Name
1st Jun 202110:31 amRNSTotal Voting Rights
26th May 20214:06 pmRNSHolding(s) in Company
25th May 20216:08 pmRNSIssue of Equity
18th May 20217:00 amRNSFull Year Results
13th Apr 20217:00 amRNSTrading Update
31st Mar 202110:29 amRNSTotal Voting Rights
3rd Mar 20216:13 pmRNSHolding(s) in Company
1st Mar 20217:00 amRNSAppointment of Eric Raab as KX CTO
1st Mar 20217:00 amRNSAppointment of Scott Matthews as CEO for MRP
26th Feb 20214:18 pmRNSIssue of Equity
26th Feb 20219:25 amRNSTotal Voting Rights
23rd Feb 20217:00 amRNSPartial sale of Quantile Technologies holding
15th Feb 20214:28 pmRNSIssue of Equity
29th Jan 20219:59 amRNSTotal Voting Rights
25th Jan 20216:18 pmRNSIssue of Equity
31st Dec 202011:17 amRNSTotal Voting Rights
9th Dec 20207:00 amRNSDirectorate Change
8th Dec 202012:46 pmRNSIssue of Equity
30th Nov 20209:35 amRNSTotal Voting Rights
16th Nov 20203:21 pmRNSHolding(s) in Company
13th Nov 20204:08 pmRNSHolding(s) in Company
12th Nov 20207:00 amRNSResult of secondary placing
30th Oct 20201:30 pmRNSIssue of Equity
27th Oct 20207:00 amRNSInterim results
12th Oct 20207:00 amRNSNotice of Results
30th Sep 20204:27 pmRNSTotal Voting Rights
16th Sep 20207:00 amRNSDirectorate Change
2nd Sep 20203:54 pmRNSIssue of Equity
2nd Sep 20207:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.